# EDGAR Filing Document

**Accession Number:** 0001832332
**File Stem:** 0001193125-26-243028
**Filing Date:** 2026-5
**Character Count:** 11122
**Document Hash:** c1c4848ff14ef7b3d3254524e990c5d6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-243028.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001193125-26-243028

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260526

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260528

**DATE AS OF CHANGE**: 20260528

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aveanna Healthcare Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001832332
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOME HEALTH CARE SERVICES [8082]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 844717209
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0101

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40362
- **FILM NUMBER:** 261028602

**BUSINESS ADDRESS:**
- **STREET 1:** 400 INTERSTATE NORTH PARKWAY
- **STREET 2:** STE 1700
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30339
- **BUSINESS PHONE:** 770-441-1580

**MAIL ADDRESS:**
- **STREET 1:** 400 INTERSTATE NORTH PARKWAY
- **STREET 2:** STE 1700
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30339

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** May 26, 2026<br>

------

![img58619535_0.jpg](img58619535_0.jpg)

Aveanna Healthcare Holdings Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-40362 | 81-4717209 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 400 Interstate North Parkway SE |  |  |
| Atlanta**,** Georgia |  | 30339 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 770 441-1580<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share | AVAH | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 8.01 Other Events.

## On May 26, 2026, Aveanna Healthcare LLC, a Delaware limited liability company (the "Borrower"), a wholly owned subsidiary of Aveanna Healthcare Holdings, Inc. (the "Company"), entered into the thirteenth amendment (the "Amendment") to its First Lien Credit Agreement, dated as of March 16, 2017 (as further amended, supplemented, or otherwise modified from time to time as of the date hereof, the "Existing Credit Agreement"), among the Borrower, Aveanna Healthcare Intermediate Holdings LLC, as Holdings, the subsidiaries of the Borrower party thereto, the lenders party thereto, Barclays Bank PLC as administrative agent and collateral agent, and other agents party thereto (the Existing Credit Agreement, as amended by the Amendment, the "Credit Agreement").

## The Amendment constitutes a repricing of the facilities under the Existing Credit Agreement resulting in a 0.50% reduction to applicable interest rate margins. Pursuant to the Amendment, the outstanding senior secured term loans under the Existing Credit Agreement were refinanced with new senior secured term loans in an aggregate principal amount of $1,318,375,000 (the "2026 Term Loans") and the existing $250,000,000 senior secured revolving credit facility was refinanced with a new $250,000,000 senior secured revolving credit facility (the "2026 Refinancing Revolving Credit Facility" and, together with the 2026 Term Loans, the "2026 Facilities"). The 2026 Term Loans bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.25% per annum or a base rate plus an applicable margin equal to 2.25% per annum. Loans under the 2026 Refinancing Revolving Credit Facility bear interest at a rate equal to, at the election of the Borrower, Term SOFR plus an applicable margin equal to 3.25% per annum or a base rate plus an applicable margin equal to 2.25% per annum, subject to adjustments based on Consolidated First Lien Net Leverage Ratio (as defined in the Credit Agreement) as of the last day of the preceding fiscal quarter.

## The Amendment further provides for a reduction of 0.25% to the applicable margins described above upon the Borrower obtaining a rating of at least B2 or B from certain credit rating agencies.

## Other terms and conditions in the Existing Credit Agreement were not materially amended as part of the Amendment.

## The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, including exhibits thereto, which the Company intends to attach as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 27, 2026.

## On May 28, 2026, the Company issued a press release announcing the Amendment. The full text of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

## Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description** |
| 99.1 | [<u>Press Release dated May 28, 2026.</u>](avah-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | AVEANNA HEALTHCARE HOLDINGS INC. |
| Date: | May 28, 2026 | By:  | /s/ Matthew Buckhalter |
|  |  |  | **Matthew Buckhalter<br>Chief Financial Officer<br>(Principal Financial Officer)** |

---

------

## Exhibit 99.1

Exhibit 99.1

![img45841609_0.jpg](img45841609_0.jpg)

**Aveanna HEALTHCARE ANNOUNCES SUCCESSFUL DEBT REPRICING**

**Atlanta, Georgia** (May 28, 2026) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (Nasdaq: AVAH), a leading, diversified home care platform focusing on providing care to medically complex, high-cost patient populations, today announced the repricing of its first lien credit facility and revolving credit facility. The repriced credit facilities provide for a 50 basis point reduction to applicable interest rate margins, as well as an additional reduction of 25 basis points to the applicable margins upon the Borrower obtaining a rating of at least B2 or B from certain credit rating agencies.

"We are encouraged by our financing partners' confidence in our commitment to operational excellence", said Matt Buckhalter, Chief Financial Officer. "We believe today's repricing of our credit facility supports our ongoing efforts to strengthen the balance sheet and provides additional flexibility as we continue executing Aveanna's strategic growth initiatives."

**About Aveanna Healthcare**

Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 39 states providing a broad range of pediatric and adult healthcare services, primarily focused on care in the home, including nursing, hospice, rehabilitation, occupational nursing in schools, therapy, and day treatment center services for medically complex and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient's normal caregiver. The Company's services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.

**Forward-Looking Statements**

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in this press release regarding our repricing of our credit facility, prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking statements. Forward-looking statements generally can be identified by the use of terminology such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "seek," "will," "may," "should," "would," "predict," "project," "potential," "continue," "could," "design," "guidance," or the negatives of these terms or variations of them or similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, the risks and uncertainties set forth under the heading "Risk Factors" in Aveanna's Annual Report on Form 10-K for its 2025 fiscal year filed with the Securities and Exchange Commission on March 19, 2026, which is available at www.sec.gov. Accordingly, forward-looking statements included in this press release do not purport to be predictions of future events or circumstances, and actual results may differ materially from those expressed by forward-looking statements. All forward-looking statements speak only as of the date made, and Aveanna undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

------

Exhibit 99.1

**Investor Contact** 

Matt Buckhalter

Chief Financial Officer

ir@aveanna.com

------